This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysts' Actions: ABT BK JNJ LULU

Stocks in this article: ABTBKJNJLULUUA

Lululemon (LULU) was downgraded at Credit Suisse from outperform to neutral. $80 price target. Comp sales growth is slowing, which could weigh on margins, Credit Suisse said.

Mattel (MAT) was upgraded at Needham from hold to buy. Company likely gained market share during the holiday season, Needham said.

Shutterfly (SFLY) was upgraded at Topeka from hold to buy. $40 price target. Have increased confidence in management's ability to deal with increased competition, Topeka said.

Texas Roadhouse (TXRH) was upgraded at Deutsche Bank from hold to buy. $20 price target. Company can continue execute in a difficult environment, Deutsche said.

Textron (TXT) was upgraded at Credit Suisse from neutral to outperform. $30 price target. Market expectations have come down to achievable levels, Credit Suisse said.

Under Armour (UA) was upgraded at Credit Suisse from neutral to outperform. $59 price target. Estimates were also boosted, as the company is leveraged to secular growth trends, Credit Suisse said.

Urban Outfitters (URBN) was upgraded at Credit Suisse from neutral to outperform. $48 price target. Estimates also boosted, given better industry trends, Credit Suisse said.

US Bancorp (USB) was upgraded at Deutsche Bank from hold to buy. $38 price target. Company is best leveraged to reform in the GSE/mortgage space, Deutsche said.

Stock Comments / EPS Changes

Dow Chemical (DOW) numbers were raised at Jefferies. Shares are now seen reaching $34. Estimates were also raised on falling feedstock prices, Jefferies said. Hold rating.

Eastman Chemical (EMN) numbers were raised at Jefferies. Shares are now seen reaching $71. Estimates also raised on lower priced feedstocks, Jefferies said. Hold rating.

Endo Health Solutions (ENDP) numbers were lowered at Oppenheimer. Shares are now seen reaching $32. Estimates were also lowered on generic competition. Outperform rating.

Endo Health Solutions numbers were lowered at UBS. Shares are now seen reaching $40. Estimates were also lowered on 2013 guidance, UBS said. Buy rating.

Family Dollar (FDO) numbers were cut at Credit Suisse. Shares are now seen reaching $65. Estimates were also reduced, given the company's new guidance, Credit Suisse said. Outperform rating.

Kohl's (KSS) estimates, target were reduced at Nomura. Estimates were reduced through 2013. Comp sales will likely fall with inventory levels, Nomura said. Neutral rating and new $41 price target.

Limited Brands (LTD) numbers lowered at Nomura. Shares are now seen reaching $52. Estimates were also cut, as the company is seeing lower sales, Nomura said. Buy rating.

PPG (PPG) numbers were raised at UBS. Shares are now seen reaching $136. Estimates were also raised on Deco paints deal, UBS said. Neutral rating.

Valero (VLO) price target was raised at Oppenheimer. Shares are now seen reaching $40. New projects improve outlook, Oppenheimer said. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,974.31 -31.44 -0.18%
S&P 500 0.00 -2.75 -0.14%
NASDAQ 4,549.2260 -15.0680 -0.33%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs